SARS-CoV-2-IN-13

Mfr.No.	T60919
Description	SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when administered orally. SARS-CoV-2-IN-13 is a potent SARS-CoV-2 inhibitor with an IC 50 of 0.057 uM (1).
Molecular Formula	C13H8Cl2N2O4
Signaling Pathways	Microbiology/Virology
Smiles	N(C(=O)C1=C(O)C=CC(Cl)=C1)C2=CC(Cl)=C(N(=O)=O)C=C2
Cas Number	56961-10-5
Molecular Weight	327.12
Target	SARS-CoV

Have you used this product?

SKU	Supplier No.	Size	Your price
BHB20430937	T60919	1 mL	$133	Add to Cart
BHB20430937	T60919	1 mg	$51	Add to Cart
BHB20430937	T60919	5 mg	$122	Add to Cart
BHB20430937	T60919	10 mg	$197	Add to Cart
BHB20430937	T60919	25 mg	$397	Add to Cart
BHB20430937	T60919	50 mg	$589	Add to Cart
BHB20430937	T60919	100 mg	$843	Add to Cart
BHB20430937	T60919	500 mg	$1730	Add to Cart